Month: August 2017

FDA: Lutathera Action Date Set for Late January 2018

Advanced Accelerator Applications S.A. (AAA) has announced that the Food and Drug Administration (FDA), in the United States, has accepted and considered complete the resubmission of the New Drug Application (NDA) for its investigational drug lutetium Lu 177 dotatate (Lutathera).  Lutathera…

Continue Reading FDA: Lutathera Action Date Set for Late January 2018

Google Doodle for NET Cancer Day? Hey, why not?

Recently, while aimlessly browsing on the Internet, I discovered a website that was trying to encourage Google to make November 10th a Google Doodle to help raise awareness of NET Cancer Day. I don’t recall that happening, ever. I figure it’s…

Continue Reading Google Doodle for NET Cancer Day? Hey, why not?

Treatment combinations for pancreatic neuroendocrine tumors

A new paper has recently been released in Digestion: International Journal of Gastroenterology that reviewed previously reported European trials. These trials specifically aimed at the treatment of advanced pancreatic neuroendocrine tumors outlined several combinations of chemotherapy drugs used to help with…

Continue Reading Treatment combinations for pancreatic neuroendocrine tumors